TetraScience’s Post

A data bottleneck slowed high-throughput screening at a biopharma. With TetraScience, data searches now take minutes instead of days, and hit selection occurs in days instead of weeks. The upshot is faster drug discovery. Download the case study to learn more: https://lnkd.in/eJBY49Ys

A data bottleneck slowed high-throughput screening at a biopharma. With TetraScience, data searches now take minutes instead of days, and hit selection occurs in days instead of weeks. The upshot is faster drug discovery. Download the case study to learn more: https://lnkd.in/dqS2-UN6

A data bottleneck was slowing high-throughput screening at a biopharma. With TetraScience, data searches now take minutes instead of days, and hit selection occurs in days instead of weeks. The upshot is faster drug discovery. Read the case study to learn more: https://lnkd.in/gjY_7-Pa

A data bottleneck slowed high-throughput screening at a biopharma. With TetraScience, data searches now take minutes instead of days, and hit selection occurs in days instead of weeks. The upshot is faster drug discovery. Download the case study to learn more: https://lnkd.in/eWKkUPig

Revolutionize #drug discovery with Birlasoft's #AI-driven solutions. Leverage our customized accelerators for interconnected study data, automated workflows, enhanced collaboration, and advanced #analytics. Go to market faster with reliability and precision. Explore digital transformation with us. https://buff.ly/3TwBzet #AI #Pharmaceuticals #bioit24 #pharma #Lifescienceindustry #medtech #Lifescience

A data bottleneck slowed high-throughput screening at a biopharma. With TetraScience, data searches now take minutes instead of days, and hit selection occurs in days instead of weeks. The upshot is faster drug discovery. Download the case study to learn more: https://lnkd.in/g3-ny72K

Heading over to my first Collision Conf! Super excited to be immersed in the tech world. I’m particularly curious to hear perspectives on AI’s impact on the life sciences. 🧬🧪👨🏼🔬🤖 If you’re going to be at the conference and want to chat about how AI is revolutionizing drug development, shoot me a message! ✅ #AI #ML #tech #collision2024 #pharma #biotech #drugformulation

GenAI is revolutionizing life sciences, accelerating drug discovery and personalizing medicine. Citizen developers are key in this innovation. Explore how AI governance can align initiatives with your goals and standards, ensuring compliance while developing cutting-edge AI solutions. Read more here: https://bit.ly/4ddHC0m #lifesciences #GenAI #AIgovernance #pharma #biotech #whitepaper #innovation

Purification plays an important role in drug discovery. Employing state-of-the-art automation that ensures rapid turnaround times and high-quality samples in line with client DMTA cycles is crucial.   Read this blog to understand more about: 🔵 How automation improves the process of high throughput purification 🔵 The role of data integration throughout the chromatographic workflow 🔵 Data-driven strategies and machine learning in a purification environment https://lnkd.in/eFFJ7Mhu #drugdiscovery #analyticalchemistry #purification #datadrivenpurification

We just published our view on global M&A trends in health industries! 🏆 Competition for innovative technologies is expected to be fierce as dealmaking headwinds begin to subside, accelerating health industries M&A in 2024. 🧱 Pharmaceuticals and life sciences (PLS) and healthcare services (HCS) M&A remained resilient in 2023, with innovative companies that can drive value attracting substantial investor interest. 🏢 Large-cap pharma companies are expected to continue pursuing midsize biotech companies to fill pipeline gaps of impending patent cliffs. 💰 Private equity firms are armed with significant dry powder which can be used to acquire or partner with healthcare assets. 💎 M&A and divestitures will likely remain the prevailing exit strategy and capital-raising mechanism for biopharma in 2024. Read more here: https://pwc.to/3S6JONI #ai #biotech #valuecreation #PwCDeals #pharma